Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Clinical trials

Research Field Neuroscience

We Need to Talk About Clinical Representation

Alzheimer’s research should benefit all, regardless of ethnicity or race

Tools & Techniques Clinical trials

The SCOPE of Things to Come

| Paulo Eduardo Stanga

It is your responsibility to encourage patients to join the SCOPE study

Research Field Clinical trials

A Rare Opportunity for Change

| Maryam Mahdi

AstraZeneca's George Kirk tells us the story of Koselugo – a treatment for the rare genetic condition neurofibromatosis 1.

Tools & Techniques Clinical trials

Trials, Interrupted

| Carl D. Regillo

Chief of the Retina Service at Wills Eye Hospital discusses the impact of COVID-19 on retina research

Tools & Techniques Clinical trials

A Framework for Translation

| Jonathan James

How strong partnerships can drive early-phase clinical trials

Tools & Techniques Cancer

Right for Patients?

| Ellen Sigal

“Right to Try” legislation may have compassion at its heart, but it does not do enough to ensure patient protection.

Tools & Techniques Drug discovery

What Women Want

| Stephanie Sutton

Women, like men, want good medicines that have been tested in clinical trials involving fair representation of both sexes.

Tools & Techniques Clinical trials

The Latest From the Cannabis Scientist

| Joanna Cummings

Talking at women in cannabis science, and meeting Raphael Mechoulam

Research Field Clinical trials

Celebrating the Digital Age

| Sophie Kornowski-Bonnet

Digital technologies could transform healthcare.

Tools & Techniques Clinical trials

Cherchez la Femme?

| Roisin McGuigan

A review of FDA data suggests that women are now better represented in clinical trials.


Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register